A systematic review of contemporary phase I trials in patients with recurrent/metastatic head and neck cancer
We performed a systematic review of phase I trials specifically conducted for patients with head and neck squamous cell carcinoma published between January 1, 2008 and August 31, 2023. PubMed and Cochrane Library databases were searched using a combination of terms: “((head and neck) OR (head &a...
Saved in:
Main Authors: | V.G. Espeli, A. Gomez, P. Balermpas, G. Treglia, A. Stathis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-09-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024004345 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials
by: B. Haridevamuthu, et al.
Published: (2024-06-01) -
Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01) -
Contemporary Issues in Head and Neck Pathology and Radiology
by: Paul C. Edwards, et al.
Published: (2010-01-01) -
Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data
by: Bogdana Patachi, et al.
Published: (2025-01-01) -
Electrochemotherapy as palliative care in patients with local or metastatic recurrence of head and neck cancer: review of state of the art
by: Francesco Cariti, et al.
Published: (2024-05-01)